potassium channel activators (Liege/Bruxelles Universities)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namepotassium channel activators (Liege/Bruxelles Universities)
Drug Alias NameBPDZ-138BPDZ-259BPDZ-490BPDZ-62BPDZ-73 +[9
ClassificationSmall molecules
Mechanisms of ActionPotassium channel agonistsInsulin release inhibitors
TargetsPotassium channel
Therapy Area/IndicationsRejection of organ transplantationDiabetes MellitusHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Liege
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationDiabetes MellitusHypertension

Other Information

ATC CodeN/A
Related LinksN/A